Can Simple MRI Characteristics Predict Molecular Subgroups in Paediatric Medulloblastoma?

INTRODUCTION: Medulloblastoma is the most common malignant paediatric central nervous system (CNS) tumour and is classified using molecular subgroups: WNT, SHH and non-WNT/non-SHH. Subgroup identification guides prognosis and treatment, but requires molecular testing, which is not universally available. MRI is routine in assessment of CNS tumours, and the MRI characteristics may serve as surrogate markers for medulloblastoma subgrouping. This study aims to use simple MRI surrogate markers identified by Perreault et al., against local medulloblastoma cases and their final molecular outcome. METHOD: Retrospective cohort study of paediatric medulloblastomas at a single tertiary children's hospital between January 2015 and October 2025. MRI studies were reviewed by a paediatric neuroradiologist and a radiology registrar in consensus. Tumours were classified by location (cerebellar hemisphere, cerebellopontine angle/cerebellar peduncle (CP/CPA), or midline/fourth ventricle) and enhancement pattern (minimal/none = < 10%, heterogeneous = 10%-90%, solid = > 90%). Associations between MRI features and molecular subgroup were assessed. RESULTS: Twenty-two cases were analysed: SHH 22.7% (5/22), WNT 13.6% (3/22) and non-WNT/non-SHH 63.7% (14/22). Most tumours were midline (90.9%), with two hemispheric lesions and no CP/CPA. Enhancement patterns were heterogeneous (54.5%), solid (36.4%) and minimal/none (9.1%). Hemispheric location was associated with SHH tumours (p = 0.043), and all WNT tumours demonstrated solid enhancement (p = 0.036). No other statistically significant associations were identified. CONCLUSION: MRI characteristics offer promising surrogate markers for medulloblastoma subtype. The only strong predictor we found corresponding with Perreault et al. is that hemispheric lesions are correlated with SHH-activated medulloblastoma. This supports further investigation of MRI markers as non-invasive and preoperative medulloblastoma subgroup prediction.

Authors

Institutions

Publication Details

Journal
Journal of Medical Imaging and Radiation Oncology
Published
2026-10-15
DOI
https://doi.org/10.1111/1754-9485.70209
Primary Topic
Glioma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Can Simple MRI Characteristics Predict Molecular Subgroups in Paediatric Medulloblastoma?

J. A. Prat-Matifoll, Robert Paul Goetti, Wilson Tao, Nigel McGregor
Journal of Medical Imaging and Radiation Oncology
Glioma Diagnosis and Treatment
article

Can Simple MRI Characteristics Predict Molecular Subgroups in Paediatric Medulloblastoma?

J. A. Prat-Matifoll, Robert Paul Goetti, Wilson Tao, Nigel McGregor
article en

Abstract

INTRODUCTION: Medulloblastoma is the most common malignant paediatric central nervous system (CNS) tumour and is classified using molecular subgroups: WNT, SHH and non-WNT/non-SHH. Subgroup identification guides prognosis and treatment, but requires molecular testing, which is not universally available. MRI is routine in assessment of CNS tumours, and the MRI characteristics may serve as surrogate markers for medulloblastoma subgrouping. This study aims to use simple MRI surrogate markers identified by Perreault et al., against local medulloblastoma cases and their final molecular outcome. METHOD: Retrospective cohort study of paediatric medulloblastomas at a single tertiary children's hospital between January 2015 and October 2025. MRI studies were reviewed by a paediatric neuroradiologist and a radiology registrar in consensus. Tumours were classified by location (cerebellar hemisphere, cerebellopontine angle/cerebellar peduncle (CP/CPA), or midline/fourth ventricle) and enhancement pattern (minimal/none = < 10%, heterogeneous = 10%-90%, solid = > 90%). Associations between MRI features and molecular subgroup were assessed. RESULTS: Twenty-two cases were analysed: SHH 22.7% (5/22), WNT 13.6% (3/22) and non-WNT/non-SHH 63.7% (14/22). Most tumours were midline (90.9%), with two hemispheric lesions and no CP/CPA. Enhancement patterns were heterogeneous (54.5%), solid (36.4%) and minimal/none (9.1%). Hemispheric location was associated with SHH tumours (p = 0.043), and all WNT tumours demonstrated solid enhancement (p = 0.036). No other statistically significant associations were identified. CONCLUSION: MRI characteristics offer promising surrogate markers for medulloblastoma subtype. The only strong predictor we found corresponding with Perreault et al. is that hemispheric lesions are correlated with SHH-activated medulloblastoma. This supports further investigation of MRI markers as non-invasive and preoperative medulloblastoma subgroup prediction.

Journal of Medical Imaging and Radiation Oncology
The University of Sydney (AU), Children's Hospital at Westmead (AU)
Openalex Percentile: Top 13%
Glioma Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.